ISTOCK, OONAL
Questions Raised About “Breakthrough” Therapies’ Clinical Support
Questions Raised About “Breakthrough” Therapies’ Clinical Support
Compared to other drugs, therapeutics given breakthrough status receive FDA approval on the basis of weaker trial evidence, a study finds.
Questions Raised About “Breakthrough” Therapies’ Clinical Support
Questions Raised About “Breakthrough” Therapies’ Clinical Support

Compared to other drugs, therapeutics given breakthrough status receive FDA approval on the basis of weaker trial evidence, a study finds.

Compared to other drugs, therapeutics given breakthrough status receive FDA approval on the basis of weaker trial evidence, a study finds.

clinical research
Two Experimental Drugs Reduce Infections in the Elderly
Two Experimental Drugs Reduce Infections in the Elderly
Sukanya Charuchandra | Jul 12, 2018
Despite the treatment being given for only six weeks, the positive effects lasted for a year.
Alan Rabson, Former Deputy Director of the NCI, Dies
Alan Rabson, Former Deputy Director of the NCI, Dies
Sukanya Charuchandra | Jul 6, 2018
Rabson’s career at the National Cancer Institute spanned six decades.
Canada Could Come to the Fore in Cannabis Research
Canada Could Come to the Fore in Cannabis Research
Ashley Yeager | Jul 6, 2018
The coming legalization of recreational marijuana is already increasing funding for studies, but regulations on such research have been slow to change.
Fresh Concerns Raised About UIC Researcher’s Pediatric Drug Study
Fresh Concerns Raised About UIC Researcher’s Pediatric Drug Study
Catherine Offord | Jul 3, 2018
New documents reveal that Mani Pavuluri had enrolled her sons as controls in a prematurely halted drug trial, a ProPublica investigation finds.
University of Gothenburg Moves to Fire Professor for Misconduct
University of Gothenburg Moves to Fire Professor for Misconduct
Kerry Grens | Jul 3, 2018
An investigation finds regenerative medicine researcher Suchitra Sumitran-Holgersson manipulated data in seven papers.
Risk of Dying Levels Off in Super Old Age: Study
Risk of Dying Levels Off in Super Old Age: Study
Kerry Grens | Jun 28, 2018
The researchers say that their results are evidence we haven’t yet reached a limit to human lifespan.
Opinion: Three-Parent Embryos—A Slippery Slope?
Opinion: Three-Parent Embryos—A Slippery Slope?
John D. Loike, Alan Kadish | Jun 14, 2018
The use of pronuclear transfer to treat infertility must first be backed by evidence it can work in cases where parents seek to avoid mitochondrial mutations.
A T-Cell Tweak Combats Advanced Breast Cancer
A T-Cell Tweak Combats Advanced Breast Cancer
Ashley Yeager | Jun 5, 2018
The immunotherapy eliminated a woman’s metastatic lesions and kept her disease-free for two years.
Immunotherapy Drug Shows Promise for Melanoma, Lung Cancer
Immunotherapy Drug Shows Promise for Melanoma, Lung Cancer
Sukanya Charuchandra | Jun 4, 2018
Merck’s Keytruda extended the lives of lung cancer patients by several months and appeared to stop the progression of advanced melanoma.